跳至主要内容
临床试验/NCT02823587
NCT02823587Unknown不适用

Effects of Pulmonary Rehabilitation on Secretion Transport, Inflammation and Respiratory System Strength and Quality of Life in Patients With Bronchiectasis

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Mucociliary transport in vivo

研究概览

简要总结

The purpose of this study is to assess the effect of pulmonary rehabilitation on the transport of secretions, inflammation and respiratory resistance, and its repercussions on the quality of life in patients with bronchiectasis.

详细描述

Bronchiectasis is characterized by pathological and irreversible dilation of bronchi caused by the inefficient removal of secretions and microorganisms and the perpetuation of inflammatory processes induced by chronic or recurrent infections, causing more damage to the airways that result in infections, and greater lesion airways and lung parenchyma. Pulmonary rehabilitation in people with bronchiectasis aims to improve exercise capacity, through effects on aerobic capacity and peripheral muscles, and to improve disease control and quality of life. The aim this study is to evaluate the effects of pulmonary rehabilitation on the transport of secretions, inflammation and respiratory resistance, and its repercussions on the quality of life in patients with bronchiectasis. In this study 60 volunteers, of both sexes, aged between 18-60 years, adequate the inclusion criteria, which will be assessed by lung function tests, the saccharin transport time, the inflammatory markers in the airways, the respiratory system resistance and quality of life scales. Volunteers will be randomly divided in pulmonary rehabilitation (PRG) and control groups (CG) that will be subdivided in bronchiectasis and healthy subgroups. In the PRG group they will receive supervised physical training twice a week and will be instructed to adopt a routine of home exercises, while CG will be informed about the benefits of physical activities. All volunteers will be evaluated after 8 weeks of the baseline and at the end of the research. Data evolution will be collected from medical records and notes of the medical team and physical therapy that will follow the routine of these participants

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • clinically stable patients
  • both sexes
  • aged between 18-60 years
  • not due to cystic fibrosis bronchiectasis diagnosis
  • non smokers
  • no pulmonary disease

排除标准

  • asthma or other restrictive conditions
  • smokers assets
  • decompensated cardiovascular and metabolic diseases, neuromuscular or musculoskeletal that impede the realization of the Protocol.

研究组 & 干预措施

Bronchiectasis Pulmonary Rehabilitation

Experimental

The volunteers will receive supervised physical training twice a week and will be instructed to adopt a routine of home exercises, for 12 weeks.

干预措施: Pulmonary Rehabilitation (Other)

Healthy Pulmonary Rehabilitation

Experimental

In this arm, the volunteers healthy will receive supervised physical training twice a week and will be instructed to adopt a routine of home exercises, for 12 weeks.

干预措施: Pulmonary Rehabilitation (Other)

Bronchiectasis Group Control

Sham Comparator

The volunteers with bronchiectasis will be informed only about the benefits of physical activities

干预措施: Control (Other)

Healthy Group Control

Sham Comparator

Volunteers healthy will be informed only about the benefits of physical activities

干预措施: Control (Other)

结局指标

主要结局

Mucociliary transport in vivo

时间窗: Through study completion, an average of 2 years.

This measurement it will be evaluated by the saccharine transport time, according to methodology (Stanley, 1984)

次要结局

  • Viscosity(Through study completion, an average of 2 years.)
  • Exhaled breath condensate(Through study completion, an average of 2 years)
  • Exhaled Nitric Oxide Fraction (FeNO)(Through study completion, an average of 2 years)
  • Cytokine Analysis TNF-α(Through study completion, an average of 2 years)
  • Cytokine Analysis IL-6(Through study completion, an average of 2 years)
  • Maximal Static Respiratory Pressures(Through study completion, an average of 2 years.)
  • Elasticity(Through study completion, an average of 2 years.)
  • Cytokine Analysis IL-10(Through study completion, an average of 2 years)
  • Mucociliary transport in vitro(Through study completion, an average of 2 years.)
  • Six Minute Walking Test(Through study completion, an average of 2 years.)
  • Quality of Life in Bronchiectasis(Through study completion, an average of 2 years.)
  • Cough Impact Assessment(Through study completion, an average of 2 years.)
  • Health-Related Quality of Life(Through study completion, an average of 2 years.)
  • Impulse Oscillometry System (IOS)(Through study completion, an average of 2 years.)
  • Pulmonary Function Test(Through study completion, an average of 2 years.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ada Clarice Gastaldi

PhD

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验